The Use of Thymidylate Synthase Inhibitors in the Treatment of Advanced Colorectal Cancer: Current Status

Oncologist - United States
doi 10.1634/theoncologist.4-6-478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Heat Shock Protein 90 Inhibitors in the Treatment of Cancer: Current Status and Future Directions

Expert Opinion on Investigational Drugs
MedicinePharmacology
2014English

Proton Pump Inhibitors Increase the Chemosensitivity of Patients With Advanced Colorectal Cancer

Oncotarget
Oncology
2017English

Translational Research in Colorectal Cancer: Current Status and Future Perspectives of Multimodal Treatment Approach

Gastroenterology Research and Practice
HepatologyGastroenterology
2019English

In SilicoScreening of the Library of Pyrimidine Derivatives as Thymidylate Synthase Inhibitors for Anticancer Activity

E-Journal of Chemistry
2009English

Current Status and Future Directions in Colorectal Cancer

Indian Journal of Surgical Oncology
SurgeryOncology
2017English

Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Thymidylate Synthase

Science-Business eXchange
2009English

Thymidylate Synthase Expression as a Predictive Biomarker of Pemetrexed Sensitivity in Advanced Non-Small Cell Lung Cancer

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2015English

Current Status of 5α-Reductase Inhibitors in the Treatment of Benign Hyperplasia of Prostate

Indian Journal of Medical Sciences
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy